Opendata, web and dolomites

CLINISC

Clinical validation of pCO2 sensor system for ischemia detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "CLINISC" data sheet

The following table provides information about the project.

Coordinator
SENSOCURE AS 

Organization address
address: RAVEIEN 205
city: BORRE
postcode: 3184
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Project website http://www.sensocure.no
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SENSOCURE AS NO (BORRE) coordinator 50˙000.00

Map

 Project objective

Sensocure has developed and patented an innovative biomedical CO2 sensor (IscAlert™) designed for the earliest possible detection of ischemia. Ischemia is a condition where the cells do not get enough oxygen to survive because of inadequate blood supply. Ischemia occurs in the form of myocardial infarction, stroke or complications after operations and accidents, and is considered the most common disease and cause of death in the Western world. This novel mass-manufacturable biosensor for ischemia detection will make an important contribution to improved medical care for the population. The long-term aim is to reduce morbidity and mortality, and thereby cost of care, for ischemia related diseases. It fits well into current medical practice by giving improved patient outcome and therefore substantially reduces healthcare costs by lowering the need for e.g. intensive care. The feasibility study will be used to plan the clinical testing of the IscAlert sensor on human patients. Clinical testing will be organized in cooperation with Oslo University Hospital and up to five European hospitals. During the feasibility study Sensocure will establish the legal framework needed for the clinical testing. The result of this work will be a detailed clinical test plan describing the kind of surgery to be undertaken, the clinics to be used, the number and kind of human patients to be addressed, the legal approval procedures and a time schedule for the said tests. The business plan to be elaborated in the feasibility study will define the various market segments and define pros and cons for using specific markets for the launch of the IscAlert product. The initial markets will be identified through the networks of hospitals involved in the above clinical tests. Following these introductory markets a network of European distributors will be established. The distributors will be identified among medical diagnostic equipment suppliers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLINISC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLINISC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More